Provided below is an assortment of links to databases and general information about grants. If there are other sites you feel belong on these pages, please e-mail email@example.com.
Community of Science (COS) Pivot
For-profit organization provides unmatched tools for discovering funding opportunities and supporting collaboration in the research development field. COS provides tools and services that enable these professionals to communicate, exchange information, and find the people and technologies that are important to their work.
Research Portfolio Online Reporting Tools (RePORT)
The information found in RePORT is drawn from several extant databases, including eRA databases, Medline, PubMed Central, the NIH Intramural Database, and iEdison, using newly formed linkages among these disparate data sources. The database includes projects funded by the National Institutes of Health, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality, and Office of the Assistant Secretary of Health.
Congressionally Directed Medical Research Programs (CDMRP)
The CDMRP website contains a searchable list of Department of Defense funding opportunities in the following areas: tuberous sclerosis complex, neurofibromatosis, ovarian cancer, prostate cancer, chronic myelogenous leukemia, and breast cancer. The site also contains publications concerning supported research.
Grants.gov allows organizations to electronically find and apply for competitive grant opportunities from all Federal grant-making agencies. Grants.gov is the single access point for more than 1,000 grant programs offered by the 26 Federal grant-making agencies. The U.S. Department of Health and Human Services is proud to be the managing partner for Grants.gov, an initiative that will have an unparalleled impact on the grant community. This site contains all grants from the CDC as well as the FDA.